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ABSTRACT
To investigate protein–protein interaction sites in
the DNA mismatch repair system we developed a
crosslinking/mass spectrometry technique employ-
ing a commercially available trifunctional cross-
linker with a thiol-specific methanethiosulfonate
group, a photoactivatable benzophenone moiety and
a biotin affinity tag. The XACM approach combines
photocrosslinking (X), in-solution digestion of the
crosslinked mixtures, affinity purification via the
biotin handle (A), chemical coding of the crosslinked
products (C) followed by MALDI-TOF mass spectro-
metry (M). We illustrate the feasibility of the method
using a single-cysteine variant of the homodimeric
DNA mismatch repair protein MutL. Moreover, we
successfully applied this method to identify the
photocrosslink formed between the single-cysteine
MutH variant A223C, labeled with the trifunctional
crosslinker in the C-terminal helix and its activator
protein MutL. The identified crosslinked MutL-
peptide maps to a conserved surface patch of the
MutL C-terminal dimerization domain. These obser-
vations are substantiated by additional mutational
and chemical crosslinking studies. Our results shed
light on the potential structures of the MutL holoen-
zyme and the MutH–MutL–DNA complex.
INTRODUCTION
DNA mismatch repair is present in almost all organisms and
required for high ﬁdelity replication of the genome (1,2).
Absence or failure of this systems leads to a mutator pheno-
type and in humans to predisposition to cancer (3). In
Escherichia coli mismatch repair is initiated by the
mismatch-binding protein MutS that after recognizing a mis-
match associates with MutL in an ATP hydrolysis-dependent
process (4). The ternary complex of MutS · MutL · DNA
activates downstream effector proteins such as the strand dis-
crimination endonuclease MutH. Activation of MutH leads to
nicking of the DNA in the unmethylated daughter strand at a
hemimethylated GATC site, which can be up to 1000 bp
away from the mismatch, thereby marking the erroneous
strand for MutS and MutL-dependent unwinding by DNA
helicase II and excision by exonucleases (1,4). In the present
study, we use MutL, a homodimeric ATPase, and one of its
effector proteins, MutH. Crystal structures are available for
the N-terminal [NTD, residues 1–331 (5)] and the C-terminal
domain [CTD, residues 432–614 (6)] of MutL and for MutH
(7,8). In vitro and in vivo studies suggest that MutL can
physically interact with MutH even in the absence of MutS
and a mismatch. A yeast-two hybrid analysis indicated that
the CTD of MutL is sufﬁcient for physical interaction with
MutH (9), while in vitro the NTD of MutL in the presence
of ATP or non-hydrolyzable analogs thereof is able to stimu-
late the latent endonuclease activity of MutH (5). In previous
studies we mapped the protein interaction sites between the
NTD of MutL and MutH via interference analysis and chem-
ical crosslinking studies (10,11).
Crosslinking in combination with proteolytic digestion
and mass spectrometric techniques is an especially attrac-
tive approach for studying protein–protein interactions
(12–15), fold recognition (16) and the topology of protein
complexes (17). Crosslinking often requires only pmol
amounts of material for analysis and is capable of capturing
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the label transfer method allowing rapid identiﬁcation of
protein–protein interaction sites at the peptide level
(14,19,20). The method relies on the commercially available
trifunctional crosslinker 2-[N
a-Benzoylbenzoicamido-N
6-(6-
biotinamidocaproyl)-L-lysinylamido]ethyl methanethiosulfo-
nate (MTS-BP-Bio), which includes a methanethiosulfonate
(MTS) moiety for SH coupling, a biotin moiety for
afﬁnity puriﬁcation using streptavidin-coated magnetic beads
and a photocrosslinking competent benzophenone moiety
(Figure 1). Photocrosslinking with benzophenone has been
used extensively as a photophysical probe to identify and
map peptide–protein interactions (21,22). Our modular
method named XACM combines well-established protocols
for (X) photocrosslinking (22), (A) afﬁnity puriﬁcation of
biotinylated peptides by streptavidin coated magnetic beads
(23) and (C) coding technologies followed by (M) mass
spectrometry identiﬁcation (24). Chemical coding generates
Figure 1. Schematic representation of XACM (X, Crosslinking; A, affinity purification; C, chemical coding and M, mass spectrometry). (A) Structure of the
trifunctional crosslinker MTS-BP-Bio. (B) Schematic representation of the XACM method used to identify protein interaction sites on the peptide level by
photocrosslinking/affinity purification/chemical coding/MALDI-TOF MS. (1) A protein is modified at thiol groups with MTS-BP-Bio thereby forminga
disulfide bond. (2) The interaction partner is added to allow complex formation (not necessary in case of obligate protein complexes). (3) Photocrosslinking of
the benzophenone moiety to the interaction partner is initiated by irradiation at 365 nm. (4) Proteins and crosslinked complexes are then digested in-solution with
proteases. (5) The crosslinked products are cleaved at their disulfide linkage thereby transferring the biotin group to the peptide of the interaction partner. (6)
The peptides bearing the biotin moiety of the crosslinker are captured on streptavidin coated magnetic beads [14]. (7) The sample is split and the biotinylated
peptides are chemically coded at their free thiol group of the crosslinker with N-methylmaleimide (NMM) or N-ethylmaleimide (NEM) to give two products
with a mass difference of 14 atomic mass units. (8) The coded peptides are combined and eluted. (9) Coded peptides are identified by MALDI-TOF MS by the
characteristic doublets separated by 14 a.m.u.
3170 Nucleic Acids Research, 2006, Vol. 34, No. 10modiﬁed peptide species with similar chemical properties
but masses separated by a characteristic mass increment
thereby facilitating identiﬁcation of the coded peptides in
mass spectra. The overall strategy of the XACM method
and the structure of the MTS-BP-Bio reagent are shown in
Figure 1.
First, we demonstrate the feasibility of the XACM method
by identifying the crosslinked peptide using a single-cysteine
variant of the homodimeric MutL protein. Second, we suc-
cessfully applied the method to investigate the photocrosslink
between the single-cysteine MutH variant A223C and its
activator protein MutL. Using the XACM technique
described here, we were able to identify the crosslinked pro-
duct between a MutH peptide comprising residue 223 and a
MutL-peptide (residues 525–541) of the CTD. These data
are in agreement with the yeast-two hybrid analysis, which
showed the interaction between MutH and the CTD of
MutL (9). By combining data from this and previous studies,
we begin to shed light on the structure of the MutH–MutL
complex.
MATERIALS AND METHODS
Strains, plasmids and reagents
E.coli K12 strain TX2652 (CC106 mutL::W4 (BsaAI;
Kan
r), TX2928 (CC106 but mutH471::tn5;Kan
r) (25) and
the pET-15b (Novagen) derived plasmids pTX412 (His6-
MutS) and pTX418 (His6-MutL) containing the genes for
hexahistidine-tagged MutS and MutL proteins, respectively,
were kindly provided by Dr M. Winkler (25). Plasmid
pMQ402 (His6-MutH), a pBAD18 derivative, containing a
gene for a MutH protein with a hexahistidine tag was a
kind gift of Dr M. Marinus (26). Plasmid pMQ402/Cys-free
coding for the cysteine-free variants of MutH (MutH
CF)
and plasmid pTX418/Cys-free coding for the cysteine-free
variant of MutL (MutL
CF) have been described before
(10,11). The E.coli strains HMS174 (lDE3) from Novagen
and XL1-blue MRF0 from Stratagene were used for protein
expression. Bacteriological media have been described
previously (11).
Site-directed mutagenesis
Single-cysteine variants of MutH at codon 223 (SC-
MutHA223C, numbering referring to the E.coli wild-type
sequence) and MutL at codon 282 (SC-MutL
A282C) were gen-
erated using plasmids pMQ402/Cys-free and pTX418/
Cys-free, respectively, by a modiﬁed Quikchange protocol
(Stratagene) essentially as described elsewhere (10,11,27).
To generate SC-MutH
A223C the oligodeoxynucleotide CAG
AAA ATG ACG aca CAG TAG TGC ACT G was used
(lower case and underlined letters indicate the exchanged
nucleotides and the codon, respectively). For SC-MutL
A282C,
the oligodeoxynucleotide CAA ACT GGG Gtg CGA TCA
GCA AC was used. Variants MutL
R531A and MutL
R531E
were generated using the plasmid pTX418 and the oligo-
deoxynucleotides GTA AAT TTT GTT GGg cTA gcG
GTA AAG GCA CT and GTA AAT TTT GTT Gtt cTA
gaG GTA AAG GCA CT, respectively. E.coli XL1-blue
MRF’ cells were transformed with the full-length PCR
products. Marker positive clones were inoculated and
grown overnight in Luria–Bertani (LB) containing ampicillin.
Plasmid DNA was isolated using the QIAprep Spin Miniprep
Kit (Qiagen) and veriﬁed by automated sequencing.
Complementation mutator assay
Cells lacking a functional chromosomal mutL gene show a
mutator phenotype, which can be analyzed by the frequency
of rifampicin resistant clones (26). Single colonies of
mutL-deﬁcient TX2652 or mutH-deﬁcient TX2928 cells
transformed with a vector control (e.g. pET-15b) or plasmids
coding for the indicated variant MutL or MutH proteins,
respectively, were cultured overnight at 37 C in 3 ml LB
media containing 100 mg/ml ampicillin. Aliquots of 50 ml
from the undiluted cultures were plated on LB agar contain-
ing 25 mg/ml ampicillin and 100 mg/ml rifampicin. Colonies
were counted after overnight incubation at 37 C.
Protein expression and purification
Recombinant His6-tagged MutH, MutL and MutS proteins
were expressed and puriﬁed by Ni-NTA chromatography
and gel ﬁltration chromatography essentially as described
before (11). MutH proteins were stored at  20 Ci n
10 mM HEPES–KOH, 500 mM KCl, 1 mM EDTA, 1 mM
DTT and 50% glycerol, pH 7.9. MutL and MutS proteins
were snap frozen in liquid nitrogen and stored at  70 C
in 10 mM HEPES–KOH, 200 mM KCl and 1 mM EDTA,
pH 7.9. Protein concentrations were determined using theo-
retical extinction coefﬁcients (28).
MutH endonuclease assay
MutH endonuclease activity was assayed on a heteroduplex
DNA substrate (484 bp) containing a G/T or A/C mismatch
at position 385 (numbering with respect to the top strand)
and a single unmethylated d(GATC) site at position 210 as
described previously (11). Brieﬂy, 25 nM of the heteroduplex
DNA was incubated at 37 C with 500 nM MutH, 2 mM MutL
and 1 mM MutS in 10 mM Tris–HCl, pH 7.9, 5 mM MgCl2,
1 mM ATP and 125 mM KCl. At suitable time points, 10 ml
aliquots were removed and the reaction stopped by addition
of 3 ml of 250 mM EDTA, 25% (w/v) sucrose, 1.2% (w/v)
SDS and 0.1% (w/v) bromophenol blue, pH 8.0, to 10 ml
aliquots. Substrates and products were separated by elec-
trophoresis on 2% agarose gels, stained with ethidium brom-
ide and analyzed using a gel imaging and analysis system
(BioDocAnalyze; Biometra). Initial rates were determined
from the linear portion of the time course.
Photocrosslinking
Protein (50–200 pmol) containing a thiol group in 50 ml
labeling buffer (125 mM KCl and 10 mM HEPES–KOH,
pH 7.5) was incubated at 25 C with a 1- to 10-fold molar
excess of MTS-BP-Bio (Toronto Research Chemicals; dis-
solved in DMSO at 36 mM) in a reaction up to several min-
utes (29). Excess reagent was removed using Protein
Desalting Spin Columns (Pierce) equilibrated with label-
ing buffer. Alternatively, proteins were labeled with 4-(N-
maleimido)benzophenone (MBP, Sigma) essentially as
described before (11). After allowing complex formation
Nucleic Acids Research, 2006, Vol. 34, No. 10 3171with an interaction partner (or directly after modiﬁcation of
an obligate protein complex) in the presence of 5 mM
MgCl2 and 1 mM non-hydrolyzable ATP analog adenosine
50-(b-g-imido)triphosphate, photocrosslinking via the benzo-
phenone moiety to neighboring amino acid residues was ini-
tiated by UV irradiation (365 nm) with a handheld UV-lamp
of 2 · 6 watt in a distance of 5 cm for 5–15 min on ice.
Crosslinking yield was assessed after separating the reaction
mixture by SDS–PAGE, Coomassie staining and analysis
using a gel imaging and analysis system (BioDocAnalyze;
Biometra) (Figure 2B).
Digestion of the photocrosslinked protein complexes
Digest of the photocrosslinking reaction mixture (50 ml) was
performed in solution for 12 h at 37 C using either 1.25 mg
trypsin (High-Sequencing-Grade ; Roche Diagnostics) or a
mixture of 1.25 mg trypsin and 2 mg endoproteinase Glu-C
(HPLC pure; Sigma). In some cases, in-gel digestions of
gel slices containing the crosslinked products were carried
out essentially as described elsewhere (11) with the exception
that the samples were modiﬁed on thiol groups with either
N-methylmaleimide or N-ethylmaleimide (Sigma). Proteases
Figure 2. Analysis of photocrosslinking SC-MutL
A282C by SDS–PAGE and MALDI-TOF MS. (A) (Partial positive ion) MALDI-TOF mass spectrum of tryptic
peptides (corresponding to 25 pmol input of SC-MutL
A282C) before affinity purification. (B) SDS–PAGE analysis (6% gels) of crosslink reactions of
homodimeric SC-MutL
A282C (5 mM) with increasing molar excess MTS-BP-Bio ranging from 1- to 20-fold. (C) MALDI-TOF spectrum after affinity purification
and chemical coding with NMM and NEM. The control peptide K1-Bio (2.5 pmol) was added prior to affinity purification (Table 1). (D) same as (C) but the
proteolysis was performed with trypsin and Glu-C. Peaks doublets labeled of the internal biotinylated control peptide K1-Bio coded with NMM and NEM
(m/z 1721.8/1735.8), and crosslinked peptides are labeled and shown in the insets (Table 1). All ions are protonated molecules and the m/z values refer to those of
monoisotopic mass. Intensities are given in arbitrary units (a.u.).
3172 Nucleic Acids Research, 2006, Vol. 34, No. 10were inactivated by addition of freshly prepared phenyl-
methlysulfonyl ﬂuoride to a ﬁnal concentration of 5 mM.
Affinity purification and chemical coding
Prior to afﬁnity puriﬁcation 35 ml of water and 10 mlo f
10· binding buffer (500 mM Tris–HCl, pH 7.4 and 10 mM
DTT) were added to 55 ml of the in-solution protease digest
mixture. For afﬁnity puriﬁcation of biotinylated crosslinked
peptides, a modiﬁed protocol of Girault et al. (23) using
streptavidin-coated (SA) magnetic beads (M-280, Dynal)
was used. After incubation and immobilization of 400 mg
SA magnetic beads with a magnetic concentrator (Dynal),
the supernatant was removed and the beads were washed
twice with 100 ml cleaning buffer (500 mM Tris–HCl,
pH 7.4, 10 mM DTT and 1 mg/ml BSA) followed by
100 ml binding buffer (50 mM Tris–HCl, pH 7.4 and 1 mM
DTT). Next the beads were mixed with 100 ml of the in-
solution protease digests (corresponding to 200 pmol protein)
spiked with 2 ml biotinylated internal control peptide K1-Bio
(20 pmol; Table 1) and incubated for 60 min at 25 C with
shaking. The supernatant was removed and the beads were
washed four times with 100 ml washing buffer [50 mM
Tris–HCl, pH 7.4 and 0.01% (v/v) N-octylglucoside], four
times with 100 ml of 1 mM DTT and ﬁnally three times
with 100 ml water. In the ﬁnal wash step, the bead solution
was split into two equal aliquots prior to removing the super-
natant. Thiol groups were chemically coded by adding 100 ml
of either freshly prepared 10 mM N-methylmaleimide or
N-ethylmaleimide in 100 mM NH4HCO3 and incubating for
60 min at 25 C in the dark with shaking. After removal of
the supernatant, beads were resuspended in 50 ml water, the
samples combined and washed again twice with 100 ml
water. Peptides were eluted with 50 ml of 0.1% (v/v) TFA,
40% (v/v) ethanol by incubation for 5–10 min at 60 C (30)
and the supernatant containing the eluted crosslinked peptides
was recovered. The beads were treated with 50 ml of 100%
acetonitrile for 60 min at 25 C and this supernatant recovered
as well. Eluates were dried in a Speedvac and stored at
 20 C for further analysis.
Mass spectrometry
Crosslinked peptides were analyzed by MALDI-MS and
candidate masses were identiﬁed by characteristic doublet
peaks. Peptides were dissolved in 4 ml of 0.1% (v/v) TFA,
40% (v/v) ethanol and 0.5 ml of this mixture was combined
with an equal volume of 10 mg/ml 2,5-dihydroxy benzoic
acid in 0.1% (w/v) TFA, 40% (v/v) ethanol, applied on
the MALDI target and allowed to crystallize using the
Table 1. Summary of control peptides and crosslinked peptides
Peptide/protein
a Sequence and
monoisotopic mass
Proteases Modification
b [M+H]
+
mono
Measured Expected
K1-Bio RDCKSTYRKD-Biotin
a
C67H111N21O21S2
[M+H]
+ ¼ 1610.78
None NMM
C5H5N1O2
111.03
1721.83 ± 0.02 1721.81
None NEM
C6H7N1O2
125.05
1735.85 ± 0.02 1735.83
MutL homocomplex
SC-MutL
A282C 267LINHAIRQAYEDK
279
C69H111N21O21
[M+H]
+ ¼ 1570.83
Trypsin NMM-S-BP-Bio
C43H57N7O8S2
863.37
2434.17 ± 0.03 2434.20
Trypsin NEM-S-BP-Bio
C44H59N7O8S2
877.39
2448.18 ± 0.04 2448.22
267LINHAIRQAYE
277
C59H94N18O17
[M+H]
+ ¼ 1327.71
Trypsin/Glu-C NMM-S-BP-Bio
C43H57N7O8S2
863.37
2191.10 ± 0.02 2191.08
Trypsin/Glu-C NEM-S-BP-Bio
C44H59N7O8S2
877.39
2205.13 ± 0.03 2205.10
MutH–MutL heterocomplex
SC-MutH
A223C
(XAM
c)
216NFTSALLCR
224
C44H73N13O13S1
[M+H]
+ ¼ 1024.52
Trypsin/Glu-C S-BP-Bio
C38H50N6O6S2
750.32
1774.78 ± 0.07 1774.85
MutL
CF
(XAM
c)
525AVPLPLRQQNLQILIPE
541
C89H152N24O24
[M+H]
+ ¼ 1942.15
Trypsin/Glu-C
216NFTSALLCR
224 + S-BP-Bio
C82H123N19O19S3
1773.84
3715.62 ± 0.4 3715.99
MutL
CF
(XACM
d)
525AVPLPLRQQNLQILIPE
541
C89H152N24O24
[M+H]
+ ¼ 1942.15
Trypsin/Glu-C NMM-S-BP-Bio
C43H57N7O8S2
863.37
2805.40 ± 0.12 2805.52
Trypsin/Glu-C NEM-S-BP-Bio
C44H59N7O8S2
877.39
2819.40 ± 0.14 2819.54
aBiotinylaminohexanoic acid.
bSee Figure 1.
cAnalysis without DTT cleavage and chemical coding.
dAnalysis after DTT cleavage and chemical coding.
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shots) were recorded with a home-built two-stage reﬂectron
time-of-ﬂight mass spectrometer (Advanced Laser Desorp-
tion Ionisation Mass Analyser II, ALADIM II) (31) in the
reﬂector mode. The instrument is equipped with a nitrogen
laser (l ¼ 337 nm, pulse duration ¼ 3 ns, energy ¼
300 mJ; VSL 337 NDS Laser; Laser Science Inc. Cambridge,
MA, USA) and externally calibrated with 1 ml of a peptide
mixture of substance P, mellitin and bovine insulin. After
assignment of monoisotopic peaks, data were analyzed with
GPMAW 6.2 (Lighthouse data).
Thiol–thiol crosslinking
Chemical crosslinking of SC-MutH
A223C to the indicated
MutL variants was performed essentially as described previ-
ously (11). Brieﬂy, proteins were incubated at 5 mM each in
20 ml labeling buffer containing 1 mM adenosine 50-(b-g-
imido)triphosphate for 10 min on ice. Crosslinking was initi-
ated at 25 C by adding 1 ml of the homobifunctional reagent
1,8-bismaleimidotetraethyleneglycol (BM[PEO]4, Pierce) to
a ﬁnal concentration of 100 mM. The reactions were
quenched after 30 s by adding DTT to a ﬁnal concentration
of 5 mM. Crosslinking reaction mixture were subjected to
SDS–PAGE and analyzed as described above. For prepara-
tive crosslinking 29 mM SC-MutH
A223C and 29 mM SC-
MutL
480C were incubated in 700 ml buffer containing
10 mM HEPES–KOH, pH 7.5, 500 mM KCl and 5 mM
MgCl2 with 145 mM homobifunctional crosslinker 3,6,9-
trioxaundecane-1,11diylbismethanethiosulfonate (MTS-11-
O3-MTS, Toronto Research Chemicals) for 5 min at 25 C.
The reaction was quenched by adding N-ethylmaleimide to
a ﬁnal concentration of 5 mM. The crosslink reaction mixture
was subjected to gel ﬁltration on a Superdex 75 column equi-
librated 10 M mM HEPES–KOH, pH 8.0, 500 mM KCl and
1 mM EDTA at 1 ml/min ﬂow rate. Fractions containing the
crosslinked complex eluting between 8 and 8.9 min were
pooled, concentrated with amicon ultra-4 (cutoff 100000;
Millipore), snap frozen in liquid nitrogen and stored at
 70 C until further analysis.
Sequence alignment and calculation of
evolutionary rates
The amino acid sequences of E.coli MutL and MutH were
used as query to search the non-redundant database (nr)
using PSI-BLAST (32). Sequences from g-proteobacteria
containing genes for both MutL and MutH homologs were
collected. Additional databases from prokaryotic genomes
available via the Genomes On Line Database (33) were
also searched. The initial multiple sequence alignment was
generated using PCMA (34) and reﬁned based on the results
of fold-recognition analysis reported by the GeneSilico Meta-
Server (35). The phylogenetic tree was calculated using the
Maximum Likelihood method implemented in PHYML (36)
based on an alignment from which columns representing
diverged regions were removed. The alignment and phylo-
genetic tree were submitted to the Consurf 3.0 server (37)
to generate normalized evolutionary rates for each position
of the alignment (low rates of divergence correspond to
high sequence conservation).
RESULTS
During DNA mismatch repair the strand discrimination endo-
nuclease MutH is activated by transient physical interaction
with MutL. In order to characterize this interaction in more
detail we developed a novel method for facilitated identiﬁ-
cation of photocrosslinking products using mass spectro-
metry. The results from this analysis were corroborated by
mutational analysis and chemical crosslinking. Moreover,
we used the identiﬁed interaction site to create and purify
an active covalently crosslinked complex of MutH and MutL.
Identification of a photocrosslinked product in the
homodimeric MutL single-cysteine variant
SC-MutL
A282C using the XACM technique
The applicability of the XACM technique is shown by
the identiﬁcation of a crosslink in the homodimeric SC-
MutL
A282C. In the structure of the NTD of MutL [pdb code
1b63, (5)] Ala282 is <20 s from the other subunit, a distance,
which is compatible with the range of the MTS-BP-Bio
crossslinker. Modiﬁcation of SC-MutL
A282C with MTS-BP-
Bio followed by photocrosslinking yields a new band on
SDS–PAGE (Figure 2B) that is also observed using the
non-cleavable photocrosslink reagent MBP. Typical cross-
linking yields were estimated to be 10–20% of the input pro-
tein. However, after standard in-gel tryptic procedures (38),
we were not able to identify any crosslinked species by
MALDI-TOF MS (Figure 2A). In contrast, using the
XACM procedure (Figure 1) we readily identiﬁed a tryptic
peptide fragment (
267LINHAIRQAYEDK
279) modiﬁed with
a chemically coded crosslinker (Figure 2C and Table 1).
This modiﬁed fragment contains one missed tryptic cleavage
site, possibly the result of photocrosslinking at or near
Arg273 such that this site is no longer recognized by trypsin.
Notably, we could not detect this fragment in the complex
mixture prior to afﬁnity puriﬁcation either from the in-
solution or the in-gel digests (data not shown). However,
after afﬁnity puriﬁcation and chemical coding the modiﬁed
peptide was often the major signal in the mass spectrum
and could be distinguished from other signals by the presence
of signal doublets separated by 14 atomic mass units. A
shortened form of this peptide (
267LINHAIRQAYE
277) was
found in the combined trypsin/Glu-C digest (Figure 2D).
Using the MutL NTD structure (5), we measured the distance
of the identiﬁed peptide to residue 282 in either the same sub-
unit (intramolecular) or the sister subunit (intermolecular).
The distances in both cases are <20 s and thus compatible
with the size of the MTS-BP-Bio crosslinker implying the
method is in principle suitable for identifying crosslinked
peptides from a complex mixture without gel electrophoretic
or chromatographic separation steps. However, in the absence
of additional data we cannot assess whether the detected
crosslink is intra- or intermolecular.
Identification of the photocrosslink product between
SC-MutH
A223C and MutL
CF
Based on the structural analysis of three different structures
of MutH in the absence of DNA and a mutational analysis
of MutH, the C-terminal helix (helix F, residues 215–224) of
MutH had been suspected to be part of the MutL interaction
site (8,26). We generated a single-cysteine variant of MutH at
3174 Nucleic Acids Research, 2006, Vol. 34, No. 10position 223 (SC-MutH
A223C) in order to probe for physical
interaction with MutL using a photocrosslinking approach.
SC-MutH
A223C modiﬁed with either MTS-BP-Bio or MBP
can be photocrosslinked to MutL
CF, suggesting that helix F
of MutH is part or close to the MutL interaction site
(Figure 3A). However, we were not able to identify a cross-
linked peptide after in-gel protease digestion and mass spec-
trometry (data not shown) using either MBP of MTS-BP-Bio
as a crosslinker. We therefore wanted to determine if the
XACM technique would allow us to identify the
crosslinked peptide. The mixture from the photocrosslinking
reaction with MTS-BP-Bio modiﬁed SC-MutH
A223C was sub-
jected to the XACM procedure making use of trypsin and
endoproteinase Glu-C. By searching for mass doublets separ-
ated by the characteristic 14 atomic mass units introduced
after chemical coding, we were able to identify a modiﬁed
peptide fragment of MutL (
525AVPLPLRQQNLQILIPE
541,
Table 1 and Figure 3B) that also contains a missed tryptic
cleavage site at Arg531. In addition, we analyzed the cross-
linking reaction mixture after proteolysis and afﬁnity
puriﬁcation but without DTT cleavage of the crosslinked pep-
tide and chemical coding using MALDI-TOF MS. A major
peak in the mass spectrum could be assigned to a cysteine-
containing peptide of MutH (
216NFTSALLCR
224) modiﬁed
with the MTS-BP-Bio crosslinker (Table 1). We were also
able to assign a peak of lower intensity to a crosslinked spe-
cies comprising the MTS-BP-Bio modiﬁed peptide from
MutH (
216NFTSALLCR
224) and the peptide from
MutL (
525AVPLPLRQQNLQILIPE
541) that we had identiﬁed
using the XACM procedure. However, in contrast to the com-
plex analysis of the uncleaved crosslinked peptides the iden-
tiﬁcation of the chemical coded peptide was much simpler.
The identiﬁed peptide of MutL is part of the CTD responsible
for dimerization (6) that has been shown by yeast-two hybrid
analysis to contain a protein interaction site for MutH (9). Fur-
ther, the identiﬁed peptide contains a highly conserved seq
uence motif in MutL (
530LRQQNLQ
536) that we predicted
previously based on bioinformatic analysis to be part of a
protein-interaction patch (39).
In vivo and in vitro activities of variants MutL
R531A and
MutL
R531E
As noted above the identiﬁed MutL crosslinked peptide frag-
ment (
525AVPLPLRQQNLQILIPE
541) contains a missed
tryptic cleavage site at Arg531. Since arginine is known to
have a high intrinsic reactivity towards photoalkylation
with benzophenone (40), we generated the two variants
MutL
R531A and MutL
R531E to remove the potential attach-
ment site for the benzophenone moiety. Given that Arg531
is part of a surface patch that is highly conserved in MutL
proteins from bacteria also containing a gene for MutH
(39), it is possible that exchanging this conserved residue
Figure 3. Analysis of photocrosslinking SC-MutH
A223C to its activator
protein MutL
CF by SDS–PAGE and MALDI-TOF MS. (A) SDS–PAGE
analysis of crosslink reactions of the heterocomplex of SC-MutH
A223C (5 mM)
modified with either 5-fold molar excess of the non-cleavable photocros-
slinker MBP in comparison with MTS-BP-Bio. After complex formation with
MutL
CF and irradiation, (365 nm 10 min) new bands are observed (H-L).
(B) Partial positive ion MALDI-TOF mass spectrum of peptides obtained by
trypsin/Glu-C digestion of the MTS-BP-Bio crosslinking reaction mixture
(corresponding to 25 pmol input of MutL) after affinity purification and
chemical coding with NMM and NEM. The control peptide K1-Bio (2.5 pmol)
was added prior to affinity purification (Table 1). All ions are protonated
molecules and the m/z values refer to those of monoisotopic mass. Intensities
are given in arbitrary units (a.u.).
Table 2. Activity of MutL and MutH variants
Variant In vivo In vitro
Median
a Range
b Activity
c (%) SE
MutL
Vector (mutL null) 1023 806–1891 N/A N/A
MutL
wt 3 0–69 100 10
MutL
CF 13 6–66 98 7
SC-MutL
A282C 1.5 0–10 72 12
MutL
R531E 120 62–280 115 5
MutL
R531A 38 0–165 91 10
MutH
vector (mutH null) 1500 79 to >5000 N/A N/A
MutH
wt 3.5 0–35 100 10
MutH
CF 1 0–16 121 9
SC-MutH
A223C 20.5 10–57 81 10
aFor in vivo activity the rpo mutation assay was used (for details see Materials
and Methods). Median number of rifampicin resistant clones which arise
by spontaneous mutation. Results obtained from 10 independent cultures.
For mutations frequencies of MutL
wt, MutL
R531A and MutL
R531E see
Supplementary Table I.
bMinimum and maximum number of rifampicin resistant clones.
cMutL activity was measured by mismatch and MutS-dependent activation of
MutH to cleave a linear 484 bp heteroduplex substrate containing a single
d(GATC) site as described in Materials and Methods. Errors shown are
±1 SD. For the dependence of the mismatch-provoked MutH activation on
the concentration of MutL
wt, MutL
R531A and MutL
R531E see Supplementary
Figure 1.
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MutL interaction with MutH or DNA. We therefore tested
both variants for their activity in vivo and in vitro. Indeed,
both plasmid-encoded MutL variants were less efﬁcient in
complementing a mutL-mutator phenotype in vivo
(Table 2). We puriﬁed both variants and tested their ability
to activate the MutH endonuclease in a mismatch and
MutS-dependent manner. Since MutL
R531A and MutL
R531E
are still able to activate the MutH endonuclease in vitro
(Table 2), we concluded that Arg531 is important for
MutL function in vivo but not essential for MutH activation
(at least under the experimental conditions used in vitro).
This implies that both MutL variants can interact func-
tionally with MutH and are therefore appropriate for probing
photocrosslinking with SC-MutH
A223C labeled with benzo-
phenone.
Figure 4. Analysis of crosslinking SC-MutH
A223C to its activator protein MutL by SDS–PAGE. (A) Photocrosslink reactions of the heterocomplex formed by
SC-MutH
A223C modified with MBP and the indicated MutL variants. After complex formation with MutL and UV-irradiation new bands are observed (H–L).
Note that both MutL
R531A and MutL
R531E fail to form a photocrosslink with SC-MutH
A223C.( B) Chemical crosslinking of SC-MutH
A223C to the indicated MutL
variants with the cysteine specific homobifunctional crosslinker BM[PEO]4. All MutL variants but MutL
CF are able to form a chemical crosslink with SC-
MutH
A223C.
3176 Nucleic Acids Research, 2006, Vol. 34, No. 10MutL
R531E and MutL
R531A are not photocrosslinked to
the SC-MutH
A223C labeled with MBP
We tested both MutL variants, R531A and R531E, for their
ability to form a photocrosslink with the SC-MutH
A223C
labeled with MBP. As shown in Figure 4A, wild-type
MutL, cysteine-free variant MutL
CF and SC-MutL
480C (39)
are able to form a photocrosslink with SC-MutH
A223C.I n
contrast, we did not observe any photocrosslink between
SC-MutH
A223C and either MutL
R531A or MutL
R531E in which
Arg531 is no longer present. This indicates that either the
acceptor amino acid for the benzophenone moiety is no
longer available or that the interaction between MutH and
the CTD of MutL has been impaired upon substitution of
Arg531 for alanine or glutamic acid. Inspection of the
MutL-CTD structure revealed the presence of a solvent
exposed cysteine residue (Cys480) at a distance of 10 s to
Arg531. Since Cys480 is the only solvent exposed cysteine
residue in the CTD of MutL, we used the long-range homobi-
functional crosslinker BM[PEO]4 to test whether Cys223 of
SC-MutH
A223C is close enough to form a crosslink. The res-
ults demonstrate that all MutL variants except MutL
CF can be
crosslinked to SC-MutH
A223C using BM[PEO]4 (Figure 4B).
This suggests that substituting Arg531 for alanine or glutamic
acid does not abolish the physical interaction of the MutL
CTD with MutH. In summary, since the variants MutL
R531A
and MutL
R531E are still able to interact with MutH both phy-
sically and functionally, we conclude that Arg531 is a likely
candidate to be the acceptor of the benzophenone moiety in
the photocrosslinking reaction with SC-MutH
A223C.T h e
absence of a photocrosslink with MutL
R531A and MutL
R531E
would thus be due to the absence of a suitable acceptor
amino acid. However, additional experiments (e.g. sequen-
cing of the photocrosslinked peptide by MS/MS) are needed
to identify unequivocally the crosslink position at the amino
acid level.
Crosslinking MutH to MutL abolish MutS requirement
to activate the MutH endonuclease
In vitro MutL is sufﬁcient to activate the MutH endonuclease
in a mismatch and MutS-independent manner (5,9). This
activation is observed at low ionic strength (<100 mM). How-
ever, at physiological relevant ionic strength [100–160 mM
(41)] optimal for DNA mismatch repair, activation of MutH
is mismatch and MutS dependent (42). Here, we investigated
the crosslinked complex between SC-MutH
A223C and
SC-MutL
480C for its MutH endonuclease activity in the
absence and presence of MutS. To this end, we employed a
chemical crosslinker (MTS-11-O3-MTS) that can be removed
upon reduction with DTT. The crosslinked complex was
puriﬁed by size-exclusion chromatography (Figure 5A).
Upon treatment with DTT, the crosslinked complex could
be cleaved. MutH in the crosslinked and uncrosslinked
(DTT-treated) form was then tested for its ability to cleave
a 484 bp long heteroduplex DNA substrate containing a
single d(GATC) site at physiological ionic strength
(125 mM KCl) in the presence and absence of MutS
(Figure 5B). In the presence of MutS, we did not observe
any difference in activity between the crosslinked and
uncrosslinked MutH-MutL, indicating that the crosslink is
not impairing the function of either MutH or MutL during
the process of mismatch- and MutS-dependent activation
of MutH. In the absence of MutS the uncrosslinked
(DTT-treated) complex was not able to cleave DNA in
buffers containing 125 mM KCl (Figure 5B); however,
stimulation was observed at lower ionic strength (50 mM
KCl; data not shown). In contrast to this, the crosslinked
complex of MutH and MutL retained the ability to cleave
DNA even at concentration of 125 mM KCl (Figure 5B).
Taken together these results suggest that crosslinking of
the C-terminal helix of MutH via position 223 to Cys480 of
the CTD of MutL did not disturb the function of the MutL–
MutH complex but rather render the complex independent
from MutS.
DISCUSSION
A key step in E.coli DNA mismatch repair is coupling mis-
match recognition by MutS and strand discrimination by
MutH (1). Various models have been proposed and most of
them involve the formation of a complex comprising MutS,
MutL and MutH (43). However, our knowledge regarding
the structure of the binary or ternary protein–protein
complexes is limited. Crosslinking has long been used to
identify interacting proteins and to map protein interaction
sites (17). However, detection of the crosslinked peptide
from the reaction mixture is often like ‘ﬁnding a needle in
the haystack’ even when employing advanced mass spectro-
metry techniques. Hence, enrichment of the crosslinked
product is often necessary for successful identiﬁcation
and several methods have been developed in recent years
(44). Here, we demonstrate that crosslink identiﬁcation in
a larger protein complex can be simpliﬁed by combining
Figure 5. Chemical crosslinking SC-MutH
A223C to SC-MutL
480C abolishes
MutS requirement for MutH activation. (A) SDS–PAGE analysis of HPLC-
purified complex SC-MutH
A223C with SC-MutL
480C crosslinked with the
cleavable reagent MTS-11-O3-MTS (for details see Materials and Methods)
before and after treatment with 5 mM DTT. The amount of uncrosslinked
SC-MutH
A223C co-purifying with the complex was judged to be <5% of the
crosslinked MutH. (B) MutH DNA cleavage promoted by MutL and MutS
was assayed as described in Materials and Methods using a 484 bp
heteroduplex DNA (25 nM). The complex of SC-MutH
A223C/SC-MutL
480C
(1 mM) crosslinked ( DTT, open symbols) or uncrosslinked (+DTT, closed
symbols) was assayed in the absence (triangles) or presence (squares) of
1 mM MutS. Note that only in the crosslinked complex MutH is able to cleave
DNA even in the absence of MutS.
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technologies prior to mass spectrometry (XACM).
The modularity of the XACM method offers several
possibilities for modiﬁcations. By thiolation of amino
groups of lysine (e.g. 2-iminothiolane or N-succinimidyl-S-
acetylthioacetate) MTS-BP-Bio can also be applied to
proteins devoid of cysteine residues. In case the proteins
contain more than one cysteine or lysine residue, however,
care must be taken to limit the number of modiﬁcations in
order to preserve a functional protein. Moreover, the com-
plexity of the reaction mixture will increase. The advantage
of the biotinylated photocrosslinker will possibly overcome
these shortcomings allowing afﬁnity puriﬁcation/enrichment
of the crosslinked species from complex mixtures. Reagents
like the amino speciﬁc Sulfo-SBED may be used instead of
MTS-BP-Bio without changing the remainder of the protocol
(45). In addition, prior to proteolytic digestions the proteins
may be puriﬁed by any method available to separate the
covalently crosslinked complex (e.g. by size exclusion
chromatography), although any additional chromatographic
or gel electrophoretic steps might result in sample loss.
The purity and the small number of derivatized peptides
offer the possibility to analyze these crosslinked products
by nano ESI-MS. Finally, any reagents available for thiol
modiﬁcation, such as described for the ICAT (46), ECAT
(47) or VICAT (48) methods, may be used instead of
chemical coding during afﬁnity puriﬁcation.
We successfully applied the XACM method presented
here to identify an as yet unknown protein–protein interaction
site at the peptide level between the CTD of MutL and a
Figure 6. Residue sequence conservation and crosslinking results mapped onto the structures of MutH (pdb code 2azo chain B), MutL NTD (pdb code 1b63) and
MutL CTD [pdb code 1x9z, (39)]. DNA taken from the structure of the co-crystal from Haemophilus influenzae MutH with specific DNA (pdb code 2aoq) has
been superimposed on the structure of E.coli MutH. MutH is shown relative to MutL NTD in an ‘open book’ view based on docking results (11). The NTD and
CTD of MutL are aligned arbitrarily to share a common dyad axis. (A) Residue sequence conservation using only protein sequences from bacteria with a gene for
both MutH and MutL was obtained using the CONSURF server (56). Conserved residues predicted to be a potential protein interaction site are labeled in yellow
(39). (B) Cartoon diagrams of MutH and MutL. The two subunits of the MutL homodimer are colored in light green and blue, respectively. Residues involved in
DNA binding (Lys159, Arg177 and Arg266) are shown as sticks colored in blue (49). Positions of cysteine residues in single-cysteine variants of MutH and MutL
are indicated as solid spheres. Positions in MutH and MutL that can be crosslink with homobifunctional reagents [Ref. (11) and this study] are shown in the same
color. The MutL-peptide crosslinked to cysteine-223 in SC-MutH
A223C modified with MTS-BP-Bio and identified using XACM is shown as sticks colored in
orange. Note that the conserved site of the CTD should face towards NTD to match all the restraints from the crosslinking experiments (for details see text).
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(Figure 3). This ﬁnding is corroborated by mutational and
additional crosslinking studies (Figure 4). Figure 6 summar-
izes our present crosslinking data on the MutL–MutH
complex. However, modeling this complex, e.g. by docking,
is a complicated task because a structure of the MutL holo-
enzyme is not available. Structures are known only for the
NTD (residues 1–331) and the CTD (residues 432–614).
Neither the structure of the 100 amino acid non-conserved
linker (residues 332–431) nor the orientation of the NTD
relative to the CTD are known. Recently, we proposed that
based on sequence-conservation analysis the conserved site
of the CTD faces the NTD (39). This proposition is corro-
borated by our crosslinking results. We have shown
previously that the protein interaction site for MutH in the
NTD is outlined by residues Asn169 and Ala251 of one sub-
unit of the homodimer and residues Gln314 and Leu327 of
the other subunit (10,11). As shown in Figure 6, the crosslink
positions in MutH and MutL identiﬁed using chemical and
photochemical crosslinkers are only compatible with a
model for the MutL holoenzyme in which the conserved
sites (residues 482–488 and 530–536) are pointing towards
the NTD, assuming that both domains share a common
dyad axis. So far, we have not been able to observe any cross-
linking between the NTD and CTD and it remains to be
shown whether these domains separated in sequence by a
100 amino acid long non-conserved linker are adjacent to
one another. It is known from other studies that the linker
length is essential for in vivo function of MutL (6).
Both MutH and MutL are DNA-binding proteins and DNA
binding of MutL has been shown to be important for mis-
match repair and DNA helicase II activation (5,6,49,50).
Under physiological relevant salt concentration, the ability
of MutL to bind to double-stranded DNA is strongly impaired
(51). MutL has a much higher afﬁnity to single-stranded
DNA or DNA with a 30-overhang compared to double-
stranded DNA (50). DNA binding in the mutant MutL
R266E
was impaired in DNA binding and stimulation of DNA
helicase II (6,50). In contrast to this, activation of MutH
by MutL is not or only slightly affected upon exchanging
residues in MutL involved in DNA binding (49,50). Hence,
it remains to be shown whether MutL is in direct contact to
the DNA in a ternary complex comprising MutL, MutH and
DNA. Moreover, it is not known whether MutH contacts both
the NTD and CTD domains of MutL prior to or after DNA
binding by MutH. Since we could demonstrate that cross-
linking MutH to the CTD domain of MutL does not affect
its ability to cleave DNA (Figure 5B), we conclude that
MutH need not to dissociate from the CTD of MutL in
order to bind and cleave DNA. Crosslinking both proteins
generates a complex that is even active in the absence of
MutS at physiological ionic strength. In addition, we observed
cleavage of a 109 bp linear homoduplex DNA and 2552 bp
supercoil plasmid DNA at 125 mM KCl in the absence of
MutS only with the crosslinked MutH/MutL complex (data
not shown). However, the mechanism by which MutL activ-
ates the MutH endonuclease is not understood in detail. It
has been discussed that MutL loads MutH onto the DNA
and/or stabilizes the active conformation of MutH (7,8,26,52).
An attractive model for stabilizing the active, closed con-
formation of MutH (8,53) might be the simultaneous binding
of MutH between the NTD and CTD (39). At physiological
salt concentration DNA-bound MutS loads MutL in an ATP-
hydrolysis-dependent process on to DNA (51,54,55). Hence,
MutH may be recruited to the DNA by MutL bound to
MutS. A possible explanation for the MutS-independent activ-
ity of the crosslinked complex of MutH and MutL may be that
upon crosslinking two MutH molecules to the MutL homodi-
mer, the DNA-binding afﬁnity of the crosslinked complex is
enhanced. Consequently, MutS may no longer be needed to
load MutL and MutH on to the DNA. Without additional
data and analysis especially regarding the mode of DNA bind-
ing of MutL in the complex, a detailed mechanistic model
remains speculative.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
The excellent technical assistance of Ina Steindorf is grate-
fully acknowledged. We thank Dr George Silva for critical
comment and helpful discussion. This work was supported
by the Deutsche Forschungsgemeinschaft (Fr-1495/3-2), the
DAAD (International quality network ‘Biochemistry of
Nucleic Acids’ and Personenbezogener Projektaustausch
Polen D/03/44623) and the Bundesministerium fu ¨r Bildung
und Forschung (BMBF; I-SCAN; 0312834A). The Open
Access publication charges for this article were waived by
Oxford University Press.
Conflict of interest statement. None declared.
REFERENCES
1. Kunkel,T.A. and Erie,D.A. (2005) DNA mismatch repair. Annu.
Rev. Biochem., 74, 681–710.
2. Schofield,M.J. and Hsieh,P. (2003) DNA mismatch repair: molecular
mechanisms and biological function. Annu. Rev. Microbiol., 57,
579–608.
3. Rowley,P.T. (2005) Inherited susceptibility to colorectal cancer.
Annu. Rev. Med., 56, 539–554.
4. Modrich,P. (1991) Mechanisms and biological effects of mismatch
repair. Annu. Rev. Genet., 25, 229–253.
5. Ban,C., Junop,M. and Yang,W. (1999) Transformation of MutL by
ATP binding and hydrolysis: a switch in DNA mismatch repair.
Cell, 97, 85–97.
6. Guarne,A., Ramon-Maiques,S., Wolff,E.M., Ghirlando,R., Hu,X.,
Miller,J.H. and Yang,W. (2004) Structure of the MutL C-terminal
domain: a model of intact MutL and its roles in mismatch repair.
EMBO J., 23, 4134–4145.
7. Lee,J.Y., Chang,J., Joseph,N., Ghirlando,R., Rao,D.N. and Yang,W.
(2005) MutH complexed with hemi- and unmethylated DNAs: coupling
base recognition and DNA cleavage. Mol. Cell, 20, 155–166.
8. Ban,C. and Yang,W. (1998) Structural basis for MutH activation in
E.coli mismatch repair and relationship of MutH to restriction
endonucleases. EMBO J., 17, 1526–1534.
9. Hall,M.C. and Matson,S.W. (1999) The Escherichia coli MutL protein
physically interacts with MutH and stimulates the MutH-associated
endonuclease activity. J. Biol. Chem., 274, 1306–1312.
10. Toedt,G., Krishnan,R. and Friedhoff,P. (2003) Site-specific protein
modification to identify the MutL interface of MutH. Nucleic Acids
Res., 31, 819–825.
11. Giron-Monzon,L., Manelyte,L., Ahrends,R., Kirsch,D., Spengler,B.
and Friedhoff,P. (2004) Mapping protein–protein interactions between
MutL and MutH by cross-linking. J. Biol. Chem., 279, 49338–49345.
Nucleic Acids Research, 2006, Vol. 34, No. 10 317912. Friedhoff,P. (2005) Mapping protein–protein interactions by
bioinformatics and cross-linking. Anal. Bioanal. Chem., 381,
78–80.
13. Rappsilber,J., Siniossoglou,S., Hurt,E.C. and Mann,M. (2000) A
generic strategy to analyze the spatial organization of multi-protein
complexes by cross-linking and mass spectrometry. Anal. Chem.,
72, 267–275.
14. Trester-Zedlitz,M., Kamada,K., Burley,S.K., Fenyo,D., Chait,B.T. and
Muir,T.W. (2003) A modular cross-linking approach for exploring
protein interactions. J. Am. Chem. Soc., 125, 2416–2425.
15. Sinz,A. (2003) Chemical cross-linking and mass spectrometry for
mapping three-dimensional structures of proteins and protein
complexes. J. Mass Spectrom., 38, 1225–1237.
16. Young,M.M., Tang,N., Hempel,J.C., Oshiro,C.M., Taylor,E.W.,
Kuntz,I.D., Gibson,B.W. and Dollinger,G. (2000) High throughput
protein fold identification by using experimental constraints derived
from intramolecular cross-links and mass spectrometry. Proc. Natl
Acad. Sci. USA, 97, 5802–5806.
17. Back,J.W., de Jong,L., Muijsers,A.O. and de Koster,C.G. (2003)
Chemical cross-linking and mass spectrometry for protein structural
modeling. J. Mol. Biol., 331, 303–313.
18. Melcher,K. (2004) New chemical crosslinking methods for the
identification of transient protein-protein interactions with multiprotein
complexes. Curr. Protein. Pept. Sci., 5, 287–296.
19. Hurst,G.B., Lankford,T.K. and Kennel,S.J. (2004) Mass spectrometric
detection of affinity purified crosslinked peptides. J. Am. Soc. Mass.
Spectrom., 15, 832–839.
20. Sinz,A. (2005) Chemical cross-linking and FTICR mass spectrometry
for protein structure characterization. Anal. Bioanal. Chem., 381,
44–47.
21. Dorman,G. and Prestwich,G.D. (1994) Benzophenone photophores in
biochemistry. Biochemistry, 33, 5661–5673.
22. Dorman,G. and Prestwich,G.D. (2000) Using photolabile ligands in
drug discovery and development. Trends Biotechnol., 18, 64–77.
23. Girault,S., Chassaing,G., Blais,J.C., Brunot,A. and Bolbach,G. (1996)
Coupling of MALDI-TOF mass analysis to the separation of
biotinylated peptides by magnetic streptavidin beads. Anal. Chem.,
68, 2122–2126.
24. Julka,S. and Regnier,F. (2004) Quantification in proteomics through
stable isotope coding: a review. J. Proteome Res., 3, 350–363.
25. Feng,G. and Winkler,M.E. (1995) Single-step purifications of
His6-MutH, His6-MutL and His6-MutS repair proteins of Escherichia
coli K-12. BioTechniques, 19, 956–965.
26. Loh,T., Murphy,K.C. and Marinus,M.G. (2001) Mutational analysis of
the MutH protein from Escherichia coli. J. Biol. Chem., 276,
12113–12119.
27. Kirsch,R.D. and Joly,E. (1998) An improved PCR-mutagenesis strategy
for two-site mutagenesis or sequence swapping between related genes.
Nucleic Acids Res., 26, 1848–1850.
28. Pace,C.N., Vajdos,F., Fee,L., Grimsley,G. and Gray,T. (1995) How to
measure and predict the molar absorption coefficient of a protein?
Protein Sci., 4, 2411–2423.
29. Karlin,A. and Akabas,M.H. (1998) Substituted-cysteine accessibility
method. Methods Enzymol., 293, 123–145.
30. Holmberg,A., Blomstergren,A., Nord,O., Lukacs,M., Lundeberg,J. and
Uhlen,M. (2005) The biotin–streptavidin interaction can be reversibly
broken using water at elevated temperatures. Electrophoresis, 26,
501–510.
31. Chaurand,P., Luetzenkirchen,F. and Spengler,B. (1999) Peptide and
protein identification by matrix-assisted laser desorption ionization
(MALDI) and MALDI-post-source decay time-of-flight mass
spectrometry. J. Am. Soc. Mass. Spectrom., 10, 91–103.
32. Altschul,S.F., Madden,T.L., Schaffer,A.A., Zhang,J., Zhang,Z.,
Miller,W. and Lipman,D.J. (1997) Gapped BLAST and PSI-BLAST: a
new generation of protein database search programs. Nucleic Acids
Res., 25, 3389–3402.
33. Liolios,K., Tavernarakis,N., Hugenholtz,P. and Kyrpides,N.C. (2006)
The Genomes On Line Database (GOLD) v.2: a monitor of genome
projects worldwide. Nucleic Acids Res., 34, D332–D334.
34. Pei,J., Sadreyev,R. and Grishin,N.V. (2003) PCMA: fast and accurate
multiple sequence alignment based on profile consistency.
Bioinformatics, 19, 427–428.
35. Kurowski,M.A. and Bujnicki,J.M. (2003) GeneSilico protein structure
prediction meta-server. Nucleic Acids Res., 31, 3305–3307.
36. Guindon,S. and Gascuel,O. (2003) A simple, fast, and accurate
algorithm to estimate large phylogenies by maximum likelihood. Syst.
Biol., 52, 696–704.
37. Glaser,F., Pupko,T., Paz,I., Bell,R.E., Bechor-Shental,D., Martz,E. and
Ben-Tal,N. (2003) ConSurf: identification of functional regions in
proteins by surface-mapping of phylogenetic information.
Bioinformatics, 19, 163–164.
38. Shevchenko,A., Wilm,M., Vorm,O. and Mann,M. (1996) Mass
spectrometric sequencing of proteins from silver-stained
polyacrylamide gels. Anal. Chem., 68, 850–858.
39. Kosinski,J., Steindorf,I., Bujnicki,J.M., Giron-Monzon,L. and
Friedhoff,P. (2005) Analysis of the quaternary structure of the MutL
C-terminal domain. J. Mol. Biol., 351, 895–909.
40. Deseke,E., Nakatani,Y. and Ourisson,G. (1998) Intrinsic reactivities of
amino acids towards photoalkylation with benzophenone—a study
preliminary to photolabelling of the transmembrane protein
glycophorin A. Eur. J. Org. Chem., 1998, 243–251.
41. Record,M.T.,Jr, Courtenay,E.S., Cayley,S. and Guttman,H.J. (1998)
Biophysical compensation mechanisms buffering E.coli
protein–nucleic acid interactions against changing environments.
Trends Biochem. Sci., 23, 190–194.
42. Friedhoff,P., Sheybani,B., Thomas,E., Merz,C. and Pingoud,A. (2002)
Haemophilus influenzae and Vibrio cholerae genes for mutH are able
to fully complement a mutH defect in Escherichia coli. FEMS
Microbiol. Lett., 208, 123–128.
43. Hays,J.B., Hoffman,P.D. and Wang,H. (2005) Discrimination
and versatility in mismatch repair. DNA Repair (Amst.), 4,
1463–1474.
44. Trakselis,M.A., Alley,S.C. and Ishmael,F.T. (2005) Identification
and mapping of protein–protein interactions by a combination of
cross-linking, cleavage, and proteomics. Bioconjug. Chem., 16,
741–750.
45. Sinz,A., Kalkhof,S. and Ihling,C. (2005) Mapping protein interfaces
by a trifunctional cross-linker combined with MALDI-TOF and
ESI-FTICR mass spectrometry. J. Am. Soc. Mass. Spectrom., 16,
1921–1931.
46. Gygi,S.P., Rist,B., Gerber,S.A., Turecek,F., Gelb,M.H. and
Aebersold,R. (1999) Quantitative analysis of complex protein mixtures
using isotope-coded affinity tags. Nat. Biotechnol., 17, 994–999.
47. Whetstone,P.A., Butlin,N.G., Corneillie,T.M. and Meares,C.F. (2004)
Element-coded affinity tags for peptides and proteins. Bioconjug.
Chem., 15, 3–6.
48. Lu,Y., Bottari,P., Turecek,F., Aebersold,R. and Gelb,M.H. (2004)
Absolute quantification of specific proteins in complex mixtures
using visible isotope-coded affinity tags. Anal. Chem., 76,
4104–4111.
49. Junop,M.S., Yang,W., Funchain,P., Clendenin,W. and Miller,J.H.
(2003) In vitro and in vivo studies of MutS, MutL and MutH mutants:
correlation of mismatch repair and DNA recombination. DNA Repair
(Amst.), 2, 387–405.
50. Robertson,A., Pattishall,S.R. and Matson,S.W. (2006) The DNA
binding activity of MutL is required for methyl-directed mismatch
repair in Escherichia coli. J. Biol. Chem., 281, 8399–8408.
51. Acharya,S., Foster,P.L., Brooks,P. and Fishel,R. (2003) The
coordinated functions of the E.coli MutS and MutL proteins in
mismatch repair. Mol. Cell, 12, 233–246.
52. Schofield,M.J., Nayak,S., Scott,T.H., Du,C. and Hsieh,P. (2001)
Interaction of Escherichia coli MutS and MutL at a DNA mismatch.
J. Biol. Chem., 276, 28291–28299.
53. Lee,B.S., Krisnanchettiar,S., Lateef,S.S. and Gupta,S. (2005) Mass
spectrometric detection of biotinylated peptides captured by avidin
functional affinity electrophoresis. Rapid Commun. Mass Spectrom.,
19, 886–892.
54. Selmane,T., Schofield,M.J., Nayak,S., Du,C. and Hsieh,P. (2003)
Formation of a DNA mismatch repair complex mediated by ATP.
J. Mol. Biol., 334, 949–965.
55. Baitinger,C., Burdett,V. and Modrich,P. (2003) Hydrolytically deficient
MutS E694Ais defective in the MutL-dependentactivation of MutH and
in the mismatch-dependent assembly of the MutS MutL heteroduplex
complex. J. Biol. Chem., 278, 49505–49511.
56. Landau,M., Mayrose,I., Rosenberg,Y., Glaser,F., Martz,E., Pupko,T.
and Ben-Tal,N. (2005) ConSurf 2005: the projection of evolutionary
conservation scores of residues on protein structures. Nucleic Acids
Res., 33, W299–W302.
3180 Nucleic Acids Research, 2006, Vol. 34, No. 10